IL169127A0 - Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin d derivative - Google Patents

Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin d derivative

Info

Publication number
IL169127A0
IL169127A0 IL169127A IL16912705A IL169127A0 IL 169127 A0 IL169127 A0 IL 169127A0 IL 169127 A IL169127 A IL 169127A IL 16912705 A IL16912705 A IL 16912705A IL 169127 A0 IL169127 A0 IL 169127A0
Authority
IL
Israel
Prior art keywords
alendronate
phosphonate
vitamin
bis
derivative
Prior art date
Application number
IL169127A
Other languages
English (en)
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of IL169127A0 publication Critical patent/IL169127A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL169127A 2002-12-16 2005-06-09 Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin d derivative IL169127A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43368502P 2002-12-16 2002-12-16
US46020603P 2003-04-02 2003-04-02
PCT/US2003/040174 WO2004058235A2 (fr) 2002-12-16 2003-12-16 Methode pouvant augmenter la biodisponibilite d'alendronate ou autre diphosphonate par administration d'une predose d'un derive de la vitamine d

Publications (1)

Publication Number Publication Date
IL169127A0 true IL169127A0 (en) 2009-02-11

Family

ID=32685268

Family Applications (1)

Application Number Title Priority Date Filing Date
IL169127A IL169127A0 (en) 2002-12-16 2005-06-09 Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin d derivative

Country Status (7)

Country Link
JP (3) JP2006514695A (fr)
AU (1) AU2003300984A1 (fr)
DE (1) DE10393906T5 (fr)
GB (1) GB2411116B (fr)
HK (1) HK1078802A1 (fr)
IL (1) IL169127A0 (fr)
WO (1) WO2004058235A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1993559T3 (en) * 2006-02-03 2016-10-03 Opko Renal Llc Treatment of vitamin D deficiency and MALFUNCTION with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
WO2007094779A1 (fr) * 2006-02-14 2007-08-23 Teva Pharmaceutical Industries Ltd. Formules pharmaceutiques de polymères d'amines aliphatiques et méthodes de fabrication desdites formules
ES2670029T3 (es) 2006-06-21 2018-05-29 Opko Ireland Global Holdings, Ltd. Terapia usando agente de repleción de la vitamina D y agente de reemplazo de la hormona de la vitamina D
WO2008074145A1 (fr) * 2006-12-20 2008-06-26 Genpharm Ulc Composition pharmaceutique comprenant un lubrifiant granulé thermofusible
US20100179110A1 (en) * 2006-12-20 2010-07-15 Mostafa Akbarieh Composition Containing a Bisphosphonic Acid in Combination with Vitamin D
CA2684778C (fr) 2007-04-25 2017-09-05 Cytochroma Inc. Procedes et composes pour une therapie a base de vitamine d
EP3225243A1 (fr) 2007-04-25 2017-10-04 Opko Renal, LLC Procédé sûr et efficace de traitement et de prévention de l'hyperparathyroïdisme secondaire dans une maladie rénale chronique
KR101495578B1 (ko) 2007-04-25 2015-02-25 사이토크로마 인코포레이티드 비타민 ｄ 부족 및 결핍의 치료 방법
DK2481400T3 (da) 2007-04-25 2014-09-29 Opko Ip Holdings Ii Inc Orale præparater med kontrolleret frigivelse omfattende en vitamin D-forbindelse og en voksagtig bærer
ES2954932T3 (es) 2008-04-02 2023-11-27 Eirgen Pharma Ltd Métodos, composiciones, usos y kits útiles para la deficiencia de vitamina D y trastornos relacionados
CN105796530A (zh) 2010-03-29 2016-07-27 赛特克罗公司 用于降低甲状旁腺水平的方法和组合物
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
IL290855B2 (en) 2016-03-28 2024-06-01 Eirgen Pharma Ltd Treatment methods using vitamin D
CN109364034B (zh) * 2018-11-26 2021-05-04 正大制药（青岛）有限公司 一种骨化三醇制剂及其制备方法
CN116211818B (zh) * 2023-03-10 2024-04-09 菲洋生物科技(吉林)有限公司 一种含有阿仑膦酸钠的片剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100317935B1 (ko) * 1999-10-20 2001-12-22 유승필 대사성 골질환 치료용 약제조성물 및 이의 제조방법
CA2454200A1 (fr) * 2001-07-17 2003-01-30 Teva Pharmaceutical Industries Ltd. Formes posologiques pour la liberation gastrique immediate d'un stimulateur de transport du calcium et la liberation gastrique retardee d'un bis-phosphonate

Also Published As

Publication number Publication date
GB2411116B (en) 2009-04-29
JP2006514695A (ja) 2006-05-11
JP2014205711A (ja) 2014-10-30
AU2003300984A8 (en) 2004-07-22
JP2011241221A (ja) 2011-12-01
WO2004058235A3 (fr) 2005-02-24
GB0511750D0 (en) 2005-07-20
AU2003300984A1 (en) 2004-07-22
GB2411116A (en) 2005-08-24
HK1078802A1 (en) 2006-03-24
DE10393906T5 (de) 2006-01-12
WO2004058235A2 (fr) 2004-07-15

Similar Documents

Publication Publication Date Title
IL169127A0 (en) Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin d derivative
AU2003280373A1 (en) Method of administering bisphosphonates
EP1477119A4 (fr) Procede d'administration de medicament
AU2003272590A1 (en) Method for ophtalmic administration of medicament
ZA200508178B (en) A method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists
EP1507559A4 (fr) Administration de medicaments conjugues a des micro-particules aux fins d'inhibition d'une stenose
PL375558A1 (en) A method of extending the dose range of vitamin d compounds
AU2002244881A1 (en) Controlled release drug delivery system of pravastatin
PT1753393T (pt) Procedimento de inoformulação de uma base galénica biocompatível
AU2003221699A1 (en) Pharmaceutical preparation for taste masking
EP1683525A4 (fr) Preparation de derives de phenylalanine a liberation soutenue pour une administration orale
AU2003270486A1 (en) Tie-back connection for subsea well
IL169352A0 (en) Improved method for the production of vitamin b12
IL165691A0 (en) Epimerization of analogs of vitamin D
EP1498420A4 (fr) Derive phospholipidique
GB0220740D0 (en) Administration of a system
EP1646640A4 (fr) Procede pour la preparation de derives de 1-androstene hautement purs
AP1925A (en) Method for the prevention of malaria
AU2003269050A1 (en) Method for decreasing bioavailability variability of an orally administered medicine
AU2003302116A1 (en) Method of preparation of derivatives of substituted 2-aryl aikanoic acids
AU2003266714A8 (en) Phospholipid derivative
AU2003244092A1 (en) 1ss-METHYLCARBAPENEM DERIVATIVE FOR ORAL ADMINISTRATION
GB0328040D0 (en) Pharmaceutical uses of bisphosphonates
AU2003226696A1 (en) Improved method for the production of vitamin b12
AU2003200836A1 (en) Method for the preparation of matairesinol

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees